stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
SCHEDULE 13G/A - Acumen Pharmaceuticals, Inc. | StockGist | StockGist
Companies
ABOS
SCHEDULE 13G/A
stock
gist
Home
Top Movers
Companies
Concepts
Filings
Toggle search
Home
Filings
ABOS
SCHEDULE 13G/A
SCHEDULE 13G/A
Beneficial Ownership
Amendment
Acumen Pharmaceuticals, Inc.
Filed Nov 4, 2025
Accepted Nov 3, 2025, 7:00 PM ET
ABOS
CIK 0001576885
View on SEC.gov
Company Profile
0000038777-25-000217
Beneficial Ownership Report
Passive Investment
% of Class
10.00%
Reporting Person
Acumen Pharmaceuticals, Inc.
Person Type
HC
CUSIP: 00509G209